Maginn
Edward Maginn, Notre Dame, IN US
Patent application number | Description | Published |
---|---|---|
20150292098 | Ionic Liquid Electrolyte and Method to Electrodeposit Metals - An electrolyte and a method to electroplate a metal on a substrate using the electrolyte are described. The electrolyte includes an imidazolium compound, a metal salt, and water. The imidazolium compound has formula (I) | 10-15-2015 |
Edward J. Maginn, South Bend, IN US
Patent application number | Description | Published |
---|---|---|
20120222557 | IONIC LIQUIDS COMPRISING HETERAROMATIC ANIONS - Some embodiments described herein relate to ionic liquids comprising an anion of a heteraromatic compound such as optionally substituted pyrrolide, optionally substituted pyrazolide, optionally substituted indolide, optionally substituted phospholide, or optionally substituted imidazolide. Methods and devices for gas separation or gas absorption related to these ionic liquids are also described herein. | 09-06-2012 |
20150034310 | COMPOUNDS, COMPOSITIONS AND METHODS FOR ENHANCING OIL RECOVERY - Described herein are compounds, compositions, and methods for enhancing oil recovery. | 02-05-2015 |
Mark Maginn, Wilburton GB
Patent application number | Description | Published |
---|---|---|
20100278839 | ANTIBODIES AGAINST NERVE GROWTH FACTOR (NGF) WITH ENHANCED IN VIVO STABILITY - The present invention provides anti-nerve growth factor (NGF) antibodies that contain an IgG4 constant region comprising a stabilizing hinge region mutation and wherein the antibodies exhibit an unexpectedly long serum half life in cynomolgus monkeys. Pharmaceutical compositions comprising the anti-NGF antibodies, nucleic acids encoding the NGF antibodies, host cells for expressing the NGF antibodies and methods of using the antibodies for treating NGF-related diseases or conditions are also provided. | 11-04-2010 |
20130295112 | Antibodies Against Nerve Growth Factor (NGF) With Enhanced In Vivo Stability - The present invention provides anti-nerve growth factor (NGF) antibodies that contain an IgG4 constant region comprising a stabilizing hinge region mutation and wherein the antibodies exhibit an unexpectedly long serum half life in cynomolgus monkeys. Pharmaceutical compositions comprising the anti-NGF antibodies, nucleic acids encoding the NGF antibodies, host cells for expressing the NGF antibodies and methods of using the antibodies for treating NGF-related diseases or conditions are also provided. | 11-07-2013 |
William Maginn, San Diego, CA US
Patent application number | Description | Published |
---|---|---|
20150124415 | PROTECTIVE COVERING FOR WEARABLE DEVICES - Embodiments of the present application relate generally to personal electronics, portable electronics, wearable electronics, and more specifically to a structure and method for a protective covering for a wearable device. Interior and exterior structures of the wearable device are configured to be flexed into a configuration and to retain the configuration after the flexing. Interior structure may include a first flexible substrate having a first relaxation structure and a second flexible substrate having a second relaxation structure. Components or other structures may be connected with the first and/or second flexible substrates. The first and second relaxation structures may be positioned relative to each other to define a flexure point. At least one flexible and electrically non-conductive cover, that may undergo shirking, may conformally cover at least a portion of the interior structure. A flexible overmolding may be formed over the cover and may comprise the exterior structure. | 05-07-2015 |